Article Details

Arcus Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides ...

Retrieved on: 2021-02-24 21:11:15

Tags for this article:

Click the tags to see associated articles and topics

Arcus Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides .... View article details on hiswai:

Excerpt

To date, PD-1 antibodies have not shown any benefit when added to G/NP in ... Domvanalimab (AB154), an anti-TIGIT monoclonal antibody and new ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up